Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections
Part of paid clinical trials in Louisville, Kentucky.
- Sponsor
- University of Louisville
- Study ID
- NCT06695585
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Neurogenic Bladder
- Overactive Bladder
- Overactive Bladder Syndrome
- Urge Incontinence
- Urinary Frequency
- Urinary Urgency
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Lidocaine 2% without vessel constrictor — DRUGdifferent volumes of intravesical 2% lidocaine without epinephrine, all patients will be receiving bladder botox but this will not be compared
Study Details
The purpose of our study is to evaluate the efficacy and safety of different volumes of bladder-numbing medication for pain relief at the time of office bladder Botox injections. This is a randomized prospective, double-blind superiority trial comparing 200 ml 2% lidocaine versus 30 ml 2% lidocaine for office Botox injections.
Key Dates
- Start date
- Dec 1, 2024
- Status verified
- Nov 2024
- Primary completion
- Jun 1, 2025
- Completion
- Dec 1, 2025
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Higher volume intravesical lidocaine200 ml of 2% lidocaine without epinephrine intravesical instillation 20-30 minutes prior to bladder botox.
- Active Comparator: Lower volume intravesical lidocaine30 ml of 2% intravesical lidocaine without epinephrine instilled into the bladder 20-30 minutes prior to bladder botox.
Primary Outcome Measure
Visual Analog Scale (VAS) [ Time Frame: on day of enrollment and procedure ]
Central Contacts
- Sean Francis, MD502-588-7660
- Laurel Carbone, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Louisville Division of Urogynecology and Reconstructive Pelvic Surgery | Louisville | Kentucky | 40202 | - |
Find similar trials in Louisville, KY
Related Studies
- Oxybutynin for Post-surgical Bladder Pain and UrgencyPHASE3 · Recruiting · University of California, Davis · Sacramento, California
- Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive BladderPHASE4 · Recruiting · Walter Reed National Military Medical Center · Bethesda, Maryland
- Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling CathetersPHASE2 · Recruiting · Medstar Health Research Institute · Washington D.C., District of Columbia
- Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead PlacementRecruiting · Loma Linda University · Loma Linda, California